DOI:
10.1055/s-00037681
Journal of Neuroanaesthesiology and Critical Care
LinksClose Window
References
Davis SM, Broderick J, Hennerici M. et al; Recombinant Activated Factor VII Intracerebral Hemorrhage Trial Investigators.
Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage.
Neurology 2006;
66 (08) 1175-1181
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.